Company / EPS (Diluted)
LIFECORE BIOMEDICAL, INC. \DE\ EPS (Diluted) History
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.38
FY2019
5-year range
-$0.43 / $0.85
FY2015-FY2019
Trend
+188.4%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) returned to growth in FY2019 after 3 years of decline, reaching $0.38.
Based on SEC 10-K filings.
0.38 in FY2019 with a 5-year CAGR of -5.0%.
Improved from $0.09 to $0.38 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -18.8%
- 5-Year CAGR
- -5.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, eps (diluted) increased 188.4% year-over-year.
- Peak eps (diluted) was recorded in FY2015.
- Lowest eps (diluted) in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2019 | $0.38 | +188.4% |
| FY2018 | -$0.43 | -577.8% |
| FY2017 | $0.09 | -87.3% |
| FY2016 | $0.71 | -16.5% |
| FY2015 | $0.85 | +73.5% |
| FY2014 | $0.49 | +226.7% |
| FY2013 | $0.15 | +0.0% |
| FY2012 | $0.15 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026